These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15172450)

  • 1. Cytomegalovirus (CMV)-specific cellular immune responses.
    Harari A; Zimmerli SC; Pantaleo G
    Hum Immunol; 2004 May; 65(5):500-6. PubMed ID: 15172450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.
    Maecker HT; Maino VC
    Hum Immunol; 2004 May; 65(5):493-9. PubMed ID: 15172449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8(+) T-cell immunity to cytomegalovirus.
    Moss P; Khan N
    Hum Immunol; 2004 May; 65(5):456-64. PubMed ID: 15172445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.
    Lacey SF; Diamond DJ; Zaia JA
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):433-47. PubMed ID: 15205665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.
    Ellefsen K; Harari A; Champagne P; Bart PA; Sékaly RP; Pantaleo G
    Eur J Immunol; 2002 Dec; 32(12):3756-64. PubMed ID: 12516570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of CD4(+) T cells in human cytomegalovirus infection.
    Gamadia LE; Rentenaar RJ; van Lier RA; ten Berge IJ
    Hum Immunol; 2004 May; 65(5):486-92. PubMed ID: 15172448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
    Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
    Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
    J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.
    Stone SF; Price P; French MA
    J Antimicrob Chemother; 2006 Apr; 57(4):585-8. PubMed ID: 16504998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of cytomegalovirus-specific cell-mediated immunity in the congenital infection.
    Hayashi N; Kimura H; Morishima T; Tanaka N; Tsurumi T; Kuzushima K
    J Med Virol; 2003 Oct; 71(2):251-8. PubMed ID: 12938200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
    Ganepola S; Gentilini C; Hilbers U; Lange T; Rieger K; Hofmann J; Maier M; Liebert UG; Niederwieser D; Engelmann E; Heilbronn R; Thiel E; Uharek L
    Bone Marrow Transplant; 2007 Mar; 39(5):293-9. PubMed ID: 17262060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
    J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid generation of CMV pp65-specific T cells for immunotherapy.
    Bao L; Sun Q; Lucas KG
    J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity.
    Na IK; Letsch A; Guerreiro M; Bauer S; Noack I; Geginat J; Reinke P; Loesch M; Kienapfel H; Thiel E; Volk HD; Scheibenbogen C
    J Immunother; 2009; 32(9):907-13. PubMed ID: 19816191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.